Drug delivery to the CNS and polymeric nanoparticulate carriers
- PMID: 21428839
- DOI: 10.4155/fmc.10.249
Drug delivery to the CNS and polymeric nanoparticulate carriers
Abstract
The delivery of drugs to the CNS is hampered by the existence of the blood-brain barrier (BBB). Nowadays, medicinal chemists follow defined rules for the development of drugs able to cross the BBB. At the same time, the parameters needed in order to gain valuable estimates of brain drug delivery are well defined. Despite the limits in molecular weight that allow drugs to cross the BBB, it was shown that nanotech products, in particular properly functionalized nanoparticles, spherical particles of approximately 200 nm in diameter, are able to cross the BBB after intravenous administration and act as drug carriers for CNS. Moreover, peptides as ligands for receptors present on the brain endothelium, or able to cross the BBB and to act as carriers for CNS drug delivery in the form of conjugates with drugs, have been discovered and started to be studied as targeting moieties for nanoparticulate systems. This article will discuss the results obtained so far in the field of nanoparticle drug carriers for CNS and highlight the parameters needed in order to fully characterize these hitherto largely unknown delivery systems. Even if promising results have been obtained, more studies are needed in order to fully evaluate the clinical potential of this drug-delivery system.
Similar articles
-
Polymeric nanoparticles for the drug delivery to the central nervous system.Expert Opin Drug Deliv. 2008 Feb;5(2):155-74. doi: 10.1517/17425247.5.2.155. Expert Opin Drug Deliv. 2008. PMID: 18248316 Review.
-
The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?Drug Discov Today. 2008 Dec;13(23-24):1099-106. doi: 10.1016/j.drudis.2008.09.005. Epub 2008 Oct 22. Drug Discov Today. 2008. PMID: 18848640 Review.
-
Chapter 3 - Colloidal systems for CNS drug delivery.Prog Brain Res. 2009;180:35-69. doi: 10.1016/S0079-6123(08)80003-9. Epub 2009 Dec 8. Prog Brain Res. 2009. PMID: 20302828 Review.
-
Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.J Control Release. 2007 Sep 11;122(1):1-9. doi: 10.1016/j.jconrel.2007.05.022. Epub 2007 May 26. J Control Release. 2007. PMID: 17651855
-
Polymeric nanoparticles - targeted drug delivery systems for treatment of CNS disorders and their possible endocrine disrupting activities.Endocr Regul. 2011 Jan;45(1):49-60. Endocr Regul. 2011. PMID: 21314211 Review.
Cited by
-
Mechanism of miR-30b-5p-Loaded PEG-PLGA Nanoparticles for Targeted Treatment of Heart Failure.Front Pharmacol. 2021 Sep 30;12:745429. doi: 10.3389/fphar.2021.745429. eCollection 2021. Front Pharmacol. 2021. PMID: 34658880 Free PMC article.
-
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model.Int J Nanomedicine. 2013;8:1749-58. doi: 10.2147/IJN.S42783. Epub 2013 May 6. Int J Nanomedicine. 2013. PMID: 23674890 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
